about
Measurement of endothelin: clinical and research use.Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system.Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.Adrenal histopathology in primary aldosteronism: is it time for a change?Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course.Oral Burning With Dysphagia and Weight Loss.Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link?Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials.Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis.Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role.Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms.Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: a retrospective cohort study.Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression.Isolation of human adrenocortical aldosterone-producing cells by a novel immunomagnetic beads method.Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism.Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients.Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.Endothelial nitric oxide synthase gene polymorphisms and renal survival.Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism.Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.Role of angiotensin II, endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis.Changes in aldosterone and obesity-related cardiometabolic risk factors with a 1-year weight loss intervention in normotensive overweight and obese young adults.Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in KCNJ5 Mutated Adenoma Cells Ex Vivo.The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua).Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension.Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design.Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide.The subtyping of primary aldosteronism by adrenal vein sampling: sequential blood sampling causes factitious lateralization.The Angiotensin Type 2 Receptor In Human Adrenocortical Zona Glomerulosa And In Aldosterone-Producing Adenoma: Low Expression And No Functional Role.A diagnostic algorithm--the holy grail of primary aldosteronism.Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.
P50
Q34057343-593315BB-1F15-45B3-80D3-49B49A100B1EQ34387386-BAC9E5C3-EC1E-4768-A00E-30B5F8298BC6Q34464823-09064A91-ACB7-464C-B322-F6656CE08110Q36053117-EC946463-8855-449F-8CF9-ABD755AD146BQ36078985-AACFECC7-8305-4C5C-8D95-090A2BEFB79BQ36194787-43872B64-8441-4576-8848-417B73B32712Q36686822-71EB45CA-A306-44F5-A780-A1E4C593180BQ36996491-46535447-5D0A-487B-92EA-03D80F33859DQ38205416-D94609C2-4B30-45AC-9C2D-E356CC879A17Q38297331-0509A3BC-A1B9-4251-9412-ACD1C022B5D9Q38699021-14946B90-180E-4B13-983D-804D8F7A5EE7Q38772266-82CA1D60-9F3E-40F0-AECD-548184BC1AA9Q38911076-E677A65E-2790-47B8-9F60-17F64BFBC23EQ38991139-7B5BC41F-73D6-4260-8144-1DA113CAA1C7Q39065150-F03CABC3-7EDD-45B6-965A-8BA2F7BCA724Q39164366-6ABABBEC-A865-40B0-92B8-6A9BD5C8DFA6Q41041170-B69F62ED-E3A8-419B-B0D9-5D22983F1B6EQ42578695-5616895E-31DF-48CC-9B7C-647338649620Q43185276-69501056-B2A6-4D61-8F60-483DCE05ABB6Q43290566-65B78698-B794-490E-A432-71E65B8A760CQ43898912-39DEC555-BB56-4C9D-8617-BDBADF310D9BQ44117739-A26F4A35-98C5-4843-8CDD-96C84B639345Q44228615-8FD239CF-D9B3-49D1-BB04-8EF426C55A07Q44323041-F1CE20CC-723B-4325-B646-78DA619A2B68Q44403665-6E572DB6-6360-47BA-9475-FCA02E814265Q45790964-2D8DB40C-7E22-4AB1-9451-3BB42518B33FQ46181622-5FBD3B8E-A1CD-490F-9018-C590604B36B2Q46270655-D7A47F2D-0735-4574-A95F-4BD5A693110EQ46354899-C0B97FB8-57DE-4998-B4AD-8E06A6BAFCA0Q47222591-0A0255F7-653D-4C76-A277-F2CB173CDF74Q47674787-50D01D0A-796E-4BC7-8C6A-00C1C8E90217Q48112698-DAB095FC-2865-4168-8A87-D68210CF8656Q48250967-F4D75B14-07F3-4967-A0A6-418E2FFFFD17Q48425884-F6DECEB4-C1A8-4A68-978C-4BF6AE02A676Q49125709-69828FA2-4A29-4A50-A6E0-01FB0BF834B3Q49337925-7D1E3929-EC69-4806-8238-47DA942B6094Q49677619-C4EBC709-E821-45A0-805B-141E1C8AF3BFQ50048305-BEE18F2C-7334-44E1-87A3-D02C6BD2C393Q51515439-B3865186-87BB-451D-941A-91542939DBFCQ51783800-58D527D8-6C4F-46DB-B8A2-D39B5DE4AC86
P50
description
researcher
@en
name
T Seccia
@en
T Seccia
@nl
type
label
T Seccia
@en
T Seccia
@nl
prefLabel
T Seccia
@en
T Seccia
@nl
P106
P31
P496
0000-0002-3639-4086